and Specific Aims.): Over the last eight years, this investigator has isolated a cDNA expressed in antigen or mitogen-stimulated T-cells, identified it as a pro-inflammatory cytokine of the beta-chemokine family, shown that it can be expressed in two forms: TCA3 and P500, and that the two forms differ in chemotactic activity (neutrophil/monocyte and monocytes/macrophages, respectively). The gene was cloned and mapped to mouse chromosome 11. Furthermore, as part of an attempt to study the biological activity of this chemokine, the investigator found that TCA3-transfected tumor cells failed to grow in syngeneic hosts. Animals transplanted with these tumors achieved specific immunity to the tumor cells (even without transfection of TCA3). The questions that will be asked in the present application are: 1. How do the structural differences in TCA3 and P500 correspond to the differences in the specificity of their chemotactic activity? TCA3 and P500 are alternate splice products of the same gene and differ extensively after amino-acid 44 (TCA3 is 69 aa's; P500 is 61aa's long). 2. What cell-types have receptors for these chemokines, and what is the biochemical structure of those receptors? 3. What is the mechanism for the inhibition of tumor growth when tumor cells produce TCA3, and what is the basis of the tumor immunity that develops?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA067416-03
Application #
2712730
Study Section
Immunobiology Study Section (IMB)
Program Officer
Finerty, John F
Project Start
1996-08-01
Project End
2001-05-31
Budget Start
1998-06-01
Budget End
1999-05-31
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Harvard University
Department
Pathology
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Zhai, Qiwei; Luo, Yi; Zhang, Ye et al. (2004) Low nuclear levels of nuclear factor-kappa B are essential for KC self-induction in astrocytes: requirements for shuttling and phosphorylation. Glia 48:327-36
Luo, Yi; Berman, Michael A; Abromson-Leeman, Sara R et al. (2003) Tumor necrosis factor is required for RANTES-induced astrocyte monocyte chemoattractant protein-1 production. Glia 43:119-27
Luo, Yi; Berman, Michael A; Zhai, Qiwei et al. (2002) RANTES stimulates inflammatory cascades and receptor modulation in murine astrocytes. Glia 39:19-30
Zhang, Ye; Zhai, Qiwei; Luo, Yi et al. (2002) RANTES-mediated chemokine transcription in astrocytes involves activation and translocation of p90 ribosomal S6 protein kinase (RSK). J Biol Chem 277:19042-8
Santambrogio, L; Belyanskaya, S L; Fischer, F R et al. (2001) Developmental plasticity of CNS microglia. Proc Natl Acad Sci U S A 98:6295-300
Fischer, F R; Luo, Y; Luo, M et al. (2001) RANTES-induced chemokine cascade in dendritic cells. J Immunol 167:1637-43
Dorf, M E; Berman, M A; Tanabe, S et al. (2000) Astrocytes express functional chemokine receptors. J Neuroimmunol 111:109-21
Fan, L; Reilly, C R; Luo, Y et al. (2000) Cutting edge: ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis. J Immunol 164:3955-9
Luo, Y; Lloyd, C; Gutierrez-Ramos, J C et al. (1999) Chemokine amplification in mesangial cells. J Immunol 163:3985-92
Santambrogio, L; Sato, A K; Fischer, F R et al. (1999) Abundant empty class II MHC molecules on the surface of immature dendritic cells. Proc Natl Acad Sci U S A 96:15050-5

Showing the most recent 10 out of 18 publications